Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature

Overview of attention for article published in Pediatric Rheumatology, November 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#27 of 751)
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 2 news outlets

twitter: 10 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 61 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Porpora di Henoch-Schonlein, rituximab efficace in casistica pedia

Pharmastar Italy, 19 Nov 2018

Il trattamento con rituximab (RTX) potrebbe rappresentare un'opzione di trattamento efficace nella cura della porpora di Henoch-S…

Rituximab Promising in Childhood Vasculitis

MedPage Today, 15 Nov 2018

Rituximab (Rituxan) may be a useful option for children with chronic steroid-dependent Henoch-Schonlein purpura, a small…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.